The Childhood Cancer Therapeutic Catalyst accelerates early-stage drug discovery for paediatric cancers by de-risking novel therapeutic opportunities through focused, milestone-driven awards in partnership with Cancer Research Horizons’ Therapeutic Innovation laboratories.
Eligibility Criteria:
-
Applicant: Established independent or transitioning clinician/non-clinical researcher with a dedicated laboratory and significant postdoctoral experience.
-
Institution: Any accredited university or research institute worldwide.
-
Scope: Early drug discovery activities only—target validation, assay/platform development, screening, feasibility studies.
Funding Details:
-
Amount: Up to 250,000 British Pounds (direct costs)
-
Duration: Up to 18 months
-
Use of Funds: Staff salaries, running expenses, outsourced research, plus in-kind support from Therapeutic Innovation.
Key Dates:
-
Expression of Interest Deadline: 10 October 2025
-
Full Proposal Deadline: To be announced (successful EoI applicants only)
How to Apply & Further Information:
- Discuss Your Proposal: Email [email protected] with a brief outline and request the EoI form.
-
Submit EoI: Complete and return the form by 10 October 2025.
-
Full Application: Invitation-only—develop proposal with assigned Therapeutic Innovation scientist.